Trial intelligence / Profile preview

Vinorelbine plus Gemcitabine vs Vinorelbine plus Cisplatin in Metastatic Breast Cancer

NCT02544243Phase 2Unknown

Sponsor
Shandong Cancer Hospital
Start
Sep 2015
Primary completion
Aug 2017
Modality
Small Molecules
01

Overview

A Phase 2 trial of gemcitabine, cisplatin in breast cancer, sponsored by Shandong Cancer Hospital. Status: unknown.

02

Drugs

gemcitabinecisplatin
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT02544243.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02544243.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call